Phase 1 Clinical Trials
The MEU is a UK leader in First in Man studies. We have considerable expertise in SAD and MAD trials. The emergence of hybrid designs, including patient cohorts, has allowed the MEU to provide a complete solution for clients seeking a single site solution for their Phase 1 programme.
Therapeutic Areas
The MEU is well-equipped to undertake large single centre early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. Our ever-expansive portfolio facilitates the MEU to undertake Phase 1 studies in many other therapeutic areas.
Facilities
State-of-the-art, hospital-based facilities including 36 inpatient beds with cardiac and telemetry monitoring, a pharmacy, clinical assessment suite, bronchoscopy unit and numerous outpatient/consultant rooms.
Recruitment
Contact us today to sense-check your protocol synopsis against our ICARUS phenotyped database of over 17,000 clinical trial volunteers. We can run inclusion/exclusion criteria in minutes, instantly checking the phenotyped data across multiple therapeutic fields.
A leader in First-In-Patient studies for over twenty years
Latest News
DIA Europe 2019: 5th – 7th February, Vienna
- Posted by The MEU
- On 4th January 2019
DIA Europe is the biggest event in the European pharmaceutical calendar, with attendees gathering from across the globe to exhibit, partner and...
GOLD releases new report for 2019
- Posted by The MEU
- On 21st November 2018
Coinciding with World COPD Day 2018, The GOLD recommendations for the management of Chronic Obstructive Pulmonary Disease (COPD) have been re-written and...
Partnerships in Clinical Trials Europe 2018
- Posted by The MEU
- On 15th October 2018
We’re looking forward to attending Partnerships in Clinical Trials Europe between 27 – 29 November, 2018 in Barcelona. Take a look at...